These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 23295311)

  • 1. IVIg prevents the in vitro activation of T cells by neutralizing the T cell activators.
    Padet L; Bazin R
    Immunol Lett; 2013 Feb; 150(1-2):54-60. PubMed ID: 23295311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin G-mediated inhibition of T-cell proliferation reflects an endogenous mechanism by which IgG modulates T-cell activation.
    MacMillan HF; Lee T; Issekutz AC
    Clin Immunol; 2009 Aug; 132(2):222-33. PubMed ID: 19447680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages.
    Andersson J; Skansén-Saphir U; Sparrelid E; Andersson U
    Clin Exp Immunol; 1996 May; 104 Suppl 1():10-20. PubMed ID: 8625537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous IgG (IVIG) and subcutaneous IgG (SCIG) preparations have comparable inhibitory effect on T cell activation, which is not dependent on IgG sialylation, monocytes or B cells.
    Issekutz AC; Rowter D; Miescher S; Käsermann F
    Clin Immunol; 2015 Oct; 160(2):123-32. PubMed ID: 25982320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costimulatory signals modulate the antiproliferative effects of agents that elevate cAMP in T cells.
    Bartik MM; Bauman GP; Brooks WH; Roszman TL
    Cell Immunol; 1994 Oct; 158(1):116-30. PubMed ID: 8087859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-induced CD3-CD4 coligation inhibits TCR/CD3 activation in the absence of costimulatory signals in normal mouse CD4(+) T lymphocytes.
    Portolés P; de Ojeda G; Criado G; Fernández-Centeno E; Rojo JM
    Cell Immunol; 1999 Aug; 195(2):96-109. PubMed ID: 10448009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential modulation of cord blood and peripheral blood monocytes by intravenous immunoglobulin.
    Gille C; Dreschers S; Spring B; Tárnok A; Bocsi J; Poets CF; Orlikowsky TW
    Cytometry B Clin Cytom; 2012 Jan; 82(1):26-34. PubMed ID: 21812105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous immunoglobulin downregulates T-cell receptor signaling and cytokine production.
    Tawfik DS; Cowan KR; Walsh AM; Hamilton WS; Goldman FD
    Pediatr Allergy Immunol; 2012 Feb; 23(1):88-95. PubMed ID: 21265884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro effects of an immunoglobulin preparation for intravenous use (IVIG) on T-cells activation.
    Sbrana S; Ruocco L; Vanacore R; Azzarà A; Ambrogi F
    Allerg Immunol (Paris); 1993 Jan; 25(1):35-7. PubMed ID: 8471137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superior immunomodulatory effects of intravenous immunoglobulins on human T-cells and dendritic cells: comparison to calcineurin inhibitors.
    Tha-In T; Metselaar HJ; Tilanus HW; Boor PP; Mancham S; Kuipers EJ; de Man RA; Kwekkeboom J
    Transplantation; 2006 Jun; 81(12):1725-34. PubMed ID: 16794540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40-CD40 ligand interaction.
    Kwekkeboom J; de Rijk D; Kasran A; Barcy S; de Groot C; de Boer M
    Eur J Immunol; 1994 Mar; 24(3):508-17. PubMed ID: 7510232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation-induced expression of MICA on T lymphocytes involves engagement of CD3 and CD28.
    Molinero LL; Fuertes MB; Rabinovich GA; Fainboim L; Zwirner NW
    J Leukoc Biol; 2002 May; 71(5):791-7. PubMed ID: 11994503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD28-mediated activation of resting human T cells without costimulation of the CD3/TCR complex.
    Siefken R; Kurrle R; Schwinzer R
    Cell Immunol; 1997 Feb; 176(1):59-65. PubMed ID: 9070318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired interleukin-2 synthesis and T cell proliferation following antibody-mediated CD3 and CD2 or CD28 cross-linking in trans: evidence that T cell activation requires the engagement of costimulatory molecules within the immunological synapse.
    Watson CL; Furlong SJ; Hoskin DW
    Immunol Invest; 2008; 37(1):63-78. PubMed ID: 18214800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cells.
    Zappasodi R; Di Nicola M; Carlo-Stella C; Mortarini R; Molla A; Vegetti C; Albani S; Anichini A; Gianni AM
    Haematologica; 2008 Oct; 93(10):1523-34. PubMed ID: 18728033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosslinking of CD27 in the presence of CD28 costimulation results in T cell proliferation and cytokine production.
    Sunder-Plassmann R; Pickl WF; Majdic O; Knapp W; Holter W
    Cell Immunol; 1995 Aug; 164(1):20-7. PubMed ID: 7634349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TCR gene-engineered T cell: limited T cell activation and combined use of IL-15 and IL-21 ensure minimal differentiation and maximal antigen-specificity.
    Pouw N; Treffers-Westerlaken E; Mondino A; Lamers C; Debets R
    Mol Immunol; 2010 Apr; 47(7-8):1411-20. PubMed ID: 20303179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD28 cosignalling does not affect the activation threshold in a chimeric antigen receptor-redirected T-cell attack.
    Chmielewski M; Hombach AA; Abken H
    Gene Ther; 2011 Jan; 18(1):62-72. PubMed ID: 20944680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro effects of everolimus and intravenous immunoglobulin on cell proliferation and apoptosis induction in the mixed lymphocyte reaction.
    Amet N; Gacad M; Petrosyan A; Pao A; Jordan SC; Toyoda M
    Transpl Immunol; 2010 Aug; 23(4):170-3. PubMed ID: 20609387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.